Cabrera Antonio G, Dyamenahalli Umesh, Gossett Jeffrey, Prodhan Parthak, Morrow W Robert, Imamura Michiaki, Jaquiss Robert D B, Bhutta Adnan T
Department of Pediatrics, University of Tennessee, Memphis/Le Bonheur Children's Medical Center, Memphis, TN, USA.
J Thorac Cardiovasc Surg. 2009 Nov;138(5):1172-9. doi: 10.1016/j.jtcvs.2009.06.016. Epub 2009 Jul 29.
Lymphopenia is a predictor of adverse clinical outcomes in adults with various systemic diseases. We hypothesized that preoperative absolute lymphopenia (absolute lymphocyte count of less than 3000 cells/microL) is associated with adverse postoperative outcomes in children with congenital heart disease undergoing corrective or palliative surgery on cardiopulmonary bypass during the first 2 years of life.
A retrospective single center cohort study was performed. Categorical variables were analyzed with the chi(2) test. Preoperative variables were analyzed with logistic and linear regression analysis to determine whether they were associated with adverse outcomes.
Analysis was performed on 280 patients, of whom 124 were female and 156 were male. Seventy-one patients were neonates (< or =30 days) at the time of the operation. Ninety patients had an absolute lymphocyte count of less than 3000 cells//microL before the operation. Regression models showed that RACHS-1 categories 5 and 6, age, and preoperative lymphopenia were significantly associated with postoperative mortality (P < .0006). Within RACHS-1 groups, lymphopenia remained a significant predictor of mortality for patients in RACHS categories 3 and 4. Lymphopenia and age were associated with longer length of stay and length of mechanical ventilation within RACHS categories 1 to 4 (P < .05). Preoperative lymphopenia was the only predictor of use of postoperative nitric oxide (P < .05).
Preoperative lymphopenia is a predictor of adverse postoperative outcomes in children with congenital heart disease who undergo a corrective or palliative procedure with cardiopulmonary bypass during the first 2 years of life.
淋巴细胞减少是患有各种全身性疾病的成年人不良临床结局的一个预测指标。我们假设术前绝对淋巴细胞减少(绝对淋巴细胞计数低于3000个细胞/微升)与1至2岁接受体外循环下矫治或姑息性手术的先天性心脏病患儿术后不良结局相关。
进行了一项回顾性单中心队列研究。分类变量采用卡方检验进行分析。术前变量采用逻辑回归和线性回归分析,以确定它们是否与不良结局相关。
对280例患者进行了分析,其中女性124例,男性156例。71例患者在手术时为新生儿(≤30天)。90例患者术前绝对淋巴细胞计数低于3000个细胞/微升。回归模型显示,RACHS-1分类5和6、年龄以及术前淋巴细胞减少与术后死亡率显著相关(P <.0006)。在RACHS-1组中,淋巴细胞减少仍然是RACHS分类3和4患者死亡率的一个显著预测指标。在RACHS分类1至4中,淋巴细胞减少和年龄与住院时间延长和机械通气时间延长相关(P <.05)。术前淋巴细胞减少是术后使用一氧化氮的唯一预测指标(P <.05)。
术前淋巴细胞减少是1至2岁接受体外循环下矫治或姑息性手术的先天性心脏病患儿术后不良结局的一个预测指标。